Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Severe CTEPH leads to an impaired physical capacity and a restricted quality of life and poor prognosis.
Pulmonary endarterectomy represents the best choice as therapy, when the thrombi are located in the central pulmonary vessels and therefore can be operated. By this operation the pulmonary artery pressure can be normalised and the patients' survival improved. Up to now, after successful endarterectomy patients only receive anticoagulation.
Despite operation many patients remain symptomatic and are restricted in their physical capacity. Therefore a hypothesis of this project is that most of the patients, even after successful operation, show peripheral vascular remodelling with a ventilation-perfusion mismatch and elevated pulmonary pressure during exercise.
In this study we aim to analyse how many patients with CTEPH after endarterectomy show elevated pulmonary artery pressures at rest or during exercise and are limited in their physical capacity, hemodynamics, oxygen uptake and quality of life and need further therapy.
Another aim is to examine whether exercise and respiratory therapy may improve the patients postoperatively.
Therefore 30 patients with CTEPH > six months after endarterectomy, with ongoing restricted exercise capacity shall be included. After baseline examination in the University hospital Heidelberg the patients receive exercise and respiratory therapy for three weeks. The patients will receive further examinations at the end of rehabilitation after 3 weeks and after 15 weeks. All examinations include medical history, family history, physical examination, ECG and echocardiography at rest and during exercise, cardiopulmonary exercise testing, assessment of the respiratory muscle strength, the SF-36 questionnaire for quality of life, laboratory testing and MRI.
Rehabilitation will be conducted in the clinic for rehabilitation Koenigstuhl, Heidelberg. Participants will be randomised into two groups, a control group receiving a conventional therapy for three weeks, in which physical exertion is to be avoided and a training group with additional exercise and respiratory therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| sedentary control group | Placebo Comparator | patients are treated by conventional rehabilitation |
|
| exercise and respiratory therapy | Active Comparator | rehabilitation with exercise and respiratory therapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| exercise and respiratory therapy | Behavioral | exercise and respiratory therapy for three weeks in-hospital and 15 weeks at home |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in 6-Minute walking test | after 3 and 15 weeks compared to baseline | |
| Change in quality of life | baseline and 15 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| physical capacity in the ergometer test | baseline, 3 and 15 weeks | |
| change of lung function during 6-minute walking test | baseline, 3 and 15 weeks | |
| noninvasive hemodynamic parameters |
Not provided
Inclusion Criteria:
A Screening
B Training
See A + all patients who showed a restricted physical capacity in the screening:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ekkehard Gruenig, MD | Contact | +49 6221 396 80 53 | ekkehard.gruenig@med.uni-heidelberg.de |
| Name | Affiliation | Role |
|---|---|---|
| Ekkehard Gruenig, MD | Thoraxclinic at the University Hospital Heidelberg | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Thoraxclinic at the University Hospital Heidelberg | Recruiting | Heidelberg | Baden-Wurttemberg | 69120 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 17449958 | Background | Mereles D, Ewert R, Lodziewski S, Borst MM, Benz A, Olschewski H, Grunig E. Effect of inhaled iloprost during off-medication time in patients with pulmonary arterial hypertension. Respiration. 2007;74(5):498-502. doi: 10.1159/000101953. Epub 2007 Apr 20. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| sedentary control group | Other | control group with no specific training |
|
| baseline, 3 and 15 weeks |
| change of systolic pulmonary arterial pressure at rest and during exercise | baseline, 3 and 15 weeks |
| change of WHO functional class | baseline, 3 and 15 weeks |
| change of perfusion parameters (MRI) | baseline, 3 and 15 weeks |
| change of respiratory muscle function | baseline and 15 weeks |
| change of NTproBNP | baseline, 3 and 15 weeks |
| ID | Term |
|---|---|
| D006976 | Hypertension, Pulmonary |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D006973 | Hypertension |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| D012138 | Respiratory Therapy |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
| D013812 | Therapeutics |
Not provided
Not provided